Effectiveness of a Treatment Switch to Nevirapine plus Tenofovir and Emtricitabine (or Lamivudine) in Adults with HIV-1 Suppressed Viremia

BACKGROUND: Switching subjects with persistently undetectable HIV-1 viremia under antiretroviral treatment (ART) to once-daily tenofovir/emtricitabine (or lamivudine) + nevirapine is a cost-effective and well-tolerated strategy. However, the effectiveness of this approach has not been established. M...

Descripción completa

Detalles Bibliográficos
Autores principales: Llibre, Josep M., Bravo, Isabel, Ornelas, Arelly, Santos, José R., Puig, Jordi, Martin-Iguacel, Raquel, Paredes, Roger, Clotet, Bonaventura
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4479501/
https://www.ncbi.nlm.nih.gov/pubmed/26107265
http://dx.doi.org/10.1371/journal.pone.0128131

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4479501/
https://www.ncbi.nlm.nih.gov/pubmed/26107265
http://dx.doi.org/10.1371/journal.pone.0128131

Ejemplares similares